Capstone Therapeutics Corp
Capstone Holding Corp., through its subsidiaries, engages in the distribution of masonry stone products in the United States. Its masonry stone products include manufactured and natural stone cladding products, natural stone landscape products and related goods for residential and commercial construction. The company was formerly known as Capstone Therapeutics Corp. and changed its name to Capsto… Read more
Capstone Therapeutics Corp (CAPS) - Total Assets
Latest total assets as of September 2024: $51.53 Million USD
Based on the latest financial reports, Capstone Therapeutics Corp (CAPS) holds total assets worth $51.53 Million USD as of September 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Capstone Therapeutics Corp - Total Assets Trend (2000–2023)
This chart illustrates how Capstone Therapeutics Corp’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Capstone Therapeutics Corp - Asset Composition Analysis
Current Asset Composition (December 2023)
Capstone Therapeutics Corp's total assets of $51.53 Million consist of 32.4% current assets and 67.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0.1% |
| Accounts Receivable | $2.58 Million | 4.9% |
| Inventory | $12.84 Million | 24.4% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $10.00K | 0.0% |
| Goodwill | $23.29 Million | 44.2% |
Asset Composition Trend (2000–2023)
This chart illustrates how Capstone Therapeutics Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Capstone Therapeutics Corp's current assets represent 32.4% of total assets in 2023, an increase from 0.0% in 2000.
- Cash Position: Cash and equivalents constituted 0.1% of total assets in 2023, down from 10.4% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 44.0% of total assets, an increase from 1.0% in 2000.
- Asset Diversification: The largest asset category is goodwill at 44.2% of total assets.
Capstone Therapeutics Corp Competitors by Total Assets
Key competitors of Capstone Therapeutics Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Burnpur Cement Limited
NSE:BURNPUR
|
India | ₹19.52 Million |
|
CSG Holding Co Ltd
SHE:000012
|
China | CN¥31.27 Billion |
|
Tangshan Jidong Cement Co Ltd
SHE:000401
|
China | CN¥58.66 Billion |
|
Chosun Refractories Co Ltd
KO:000480
|
Korea | ₩1.60 Trillion |
|
Gansu Shangfeng Cement Co Ltd
SHE:000672
|
China | CN¥16.88 Billion |
|
Jiangxi Wannianqing Cement Co Ltd
SHE:000789
|
China | CN¥15.80 Billion |
|
Xinjiang Tianshan Cement Co Ltd
SHE:000877
|
China | CN¥289.73 Billion |
|
Sinostone Guangdong Co Ltd
SHE:001212
|
China | CN¥2.25 Billion |
Capstone Therapeutics Corp - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Capstone Therapeutics Corp generates 0.92x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Capstone Therapeutics Corp is currently not profitable relative to its asset base.
Capstone Therapeutics Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.07 | 1.38 | 0.25 |
| Quick Ratio | 0.36 | 0.34 | 0.25 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $1.01 Million | $ 5.42 Million | $ -871.00K |
Capstone Therapeutics Corp - Advanced Valuation Insights
This section examines the relationship between Capstone Therapeutics Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.60 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -19.2% |
| Total Assets | $52.70 Million |
| Market Capitalization | $80.00K USD |
Valuation Analysis
Below Book Valuation: The market values Capstone Therapeutics Corp's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Capstone Therapeutics Corp's assets decreased by 19.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Capstone Therapeutics Corp (2000–2023)
The table below shows the annual total assets of Capstone Therapeutics Corp from 2000 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | $52.70 Million | -19.19% |
| 2022-12-31 | $65.21 Million | +7.16% |
| 2021-12-31 | $60.85 Million | +10.90% |
| 2020-12-31 | $54.87 Million | +19221.83% |
| 2019-12-31 | $284.00K | -80.77% |
| 2018-12-31 | $1.48 Million | -5.86% |
| 2017-12-31 | $1.57 Million | +32.74% |
| 2016-12-31 | $1.18 Million | -33.11% |
| 2015-12-31 | $1.77 Million | -47.80% |
| 2014-12-31 | $3.38 Million | -53.74% |
| 2013-12-31 | $7.32 Million | -36.87% |
| 2012-12-31 | $11.59 Million | -21.13% |
| 2011-12-31 | $14.70 Million | -41.89% |
| 2010-12-31 | $25.29 Million | -31.90% |
| 2009-12-31 | $37.13 Million | -25.00% |
| 2008-12-31 | $49.51 Million | -19.96% |
| 2007-12-31 | $61.86 Million | -14.78% |
| 2006-12-31 | $72.59 Million | -17.83% |
| 2005-12-31 | $88.34 Million | -23.30% |
| 2004-12-31 | $115.18 Million | -11.47% |
| 2003-12-31 | $130.11 Million | +143.55% |
| 2002-12-31 | $53.42 Million | +7.49% |
| 2001-12-31 | $49.70 Million | -23.58% |
| 2000-12-31 | $65.03 Million | -- |